We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CW icon
6076
CALL
Curtiss-Wright
CW
$25.8B
$341K ﹤0.01%
2,800
-2,900
-51% -$342K
NGG icon
6077
CALL
National Grid
NGG
$81.5B
$341K ﹤0.01%
6,558
-3,053
-32% -$163K
TRHC
6078
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$341K ﹤0.01%
+12,172
New +$357K
ACOR
6079
PUT
DELISTED
Acorda Therapeutics
ACOR
$341K ﹤0.01%
133
-131
-50% -$372K
DNO
6080
CALL
DELISTED
United States Short Oil Fund
DNO
$341K ﹤0.01%
6,000
-5,900
-50% -$366K
BWP
6081
CALL
DELISTED
Boardwalk Pipeline Partners
BWP
$341K ﹤0.01%
+26,400
New +$373K
TEN
6082
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$340K ﹤0.01%
5,800
-2,000
-26% -$118K
CCXI
6083
DELISTED
ChemoCentryx, Inc.
CCXI
$340K ﹤0.01%
57,123
+10,744
+23% +$73.7K
SHLX
6084
CALL
DELISTED
Shell Midstream Partners, L.P.
SHLX
$340K ﹤0.01%
11,400
+400
+4% +$10.9K
ASMB icon
6085
PUT
Assembly Biosciences
ASMB
$671M
$339K ﹤0.01%
+625
New +$283K
NG icon
6086
NovaGold Resources
NG
$3.48B
$339K ﹤0.01%
86,357
+34,939
+68% +$139K
SBLK icon
6087
Star Bulk Carriers
SBLK
$3.24B
$339K ﹤0.01%
+30,071
New +$312K
SPLV icon
6088
PUT
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
$339K ﹤0.01%
+7,100
New +$335K
TPH
6089
PUT
DELISTED
Tri Pointe Homes
TPH
$339K ﹤0.01%
18,900
+8,300
+78% +$140K
AIFU
6090
AIFU Inc
AIFU
$215M
$339K ﹤0.01%
+39
New +$291K
DBKO
6091
DELISTED
Xtrackers MSCI South Korea Hedged Equity ETF
DBKO
$339K ﹤0.01%
+10,794
New +$337K
SXCP
6092
CALL
DELISTED
SunCoke Energy Partners, L.P.
SXCP
$339K ﹤0.01%
19,400
+3,500
+22% +$61K
HRG
6093
PUT
DELISTED
HRG Group, Inc.
HRG
$339K ﹤0.01%
+20,000
New +$323K
LCII icon
6094
PUT
LCI Industries
LCII
$2.58B
$338K ﹤0.01%
+2,600
New +$320K
MTW icon
6095
PUT
Manitowoc
MTW
$746M
$338K ﹤0.01%
8,600
+5,700
+197% +$220K
NG icon
6096
CALL
NovaGold Resources
NG
$3.48B
$338K ﹤0.01%
85,900
+20,500
+31% +$81.5K
LGF.A
6097
CALL
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$338K ﹤0.01%
10,000
-1,500
-13% -$47.2K
AVID
6098
DELISTED
Avid Technology Inc
AVID
$338K ﹤0.01%
62,777
+27,070
+76% +$146K
AES icon
6099
CALL
AES
AES
$10.5B
$337K ﹤0.01%
31,100
+6,500
+26% +$70.3K
ECPG icon
6100
CALL
Encore Capital Group
ECPG
$2.2B
$337K ﹤0.01%
+8,000
New +$365K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.